A review by The Recorder of SEC filings for 17 companies that had prominent Silicon Valley lawyers serving as directors has uncovered questionable option grant dates for executives at five. While the grant patterns aren't necessarily evidence of wrongdoing, they do suggest that suspect pay practices at startups may be more commonplace than previously thought. They also raise new questions about what some name-brand lawyers knew, or should have known, in their roles as directors.
August 28, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.com
For Amylin Pharmaceuticals Inc., 1998 was a rough year. Poor results in a series of clinical trials caused the company to lay off 80 percent of its workers. By Oct. 22, the company’s shares had fallen from $6.62 to a low of 31 cents.
The shares began to climb, though, as the company figured out what had gone wrong in the clinical trials.
Presented by BigVoodoo
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
BTI provides leading tax professionals from financial institutions with unmatched tools and resources.
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Our client, a small but highly sophisticated and entrepreneurial tax boutique in Charleston, SC, has asked for our firm s assistance in iden...
CORE RESPONSIBILITIES AND TASKS:(1) Tasks and responsibilities include:Reviewing and negotiating commercial agreements for internal business...
Boutique midtown Manhattan law firm specializing in sophisticated real estate litigation & representation of commercial and residential ...
